Retatrutide [GLP – 3 (R)] Research Overview
Retatrutide is an investigational synthetic peptide that functions as a triple receptor agonist, simultaneously targeting three essential metabolic pathways. It is engineered to balance agonism across the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors.
Mechanism of Action
- GLP-1 Receptor Enhances insulin secretion, slows gastric emptying, suppresses appetite, and prolongs satiety.
- GIP Receptor Stimulates insulin release after meals and contributes to weight reduction.
- Glucagon Receptor (GCGR) Increases energy expenditure and fat metabolism, promoting calorie burning.
Research Benefits & Applications
In preclinical research settings, Retatrutide is studied for the following potential effects:
- Weight Management May promote significant weight loss by reducing appetite and increasing energy expenditure.
- Metabolic Health Improves insulin sensitivity and lowers blood sugar levels.
- Adipose Tissue Research Utilized in studies involving lipid mobilization, mitochondrial efficiency, and the activation of brown adipose tissue.
- Cardiovascular Support Studied for potential benefits to overall cardiovascular health.
Potential Risks & Side Effects
Researchers should monitor for the following documented risks associated with Retatrutide:
- Gastrointestinal discomfort, including nausea.
- Fatigue and potential low blood sugar (hypoglycemia).
- Risk of muscle loss if misused.
- Unknown long-term systemic effects.
Product Specifications
| Feature | Specification |
|---|---|
| Molecular Weight | ~5100 Da |
| Form | Lyophilized (Freeze-Dried) Powder |
| Purity | >99% (HPLC Verified) |
| Storage | Cool, dry environment; refrigerate at 2°C–8°C after reconstitution |
Safety Precautions & Compliance
⚠️ FOR RESEARCH USE ONLYThis compound is provided exclusively for in vitro laboratory research. It is strictly prohibited for human or animal consumption, medical use, or therapeutic application.
- Reconstitution Requires careful reconstitution prior to use. Staff will not provide guidance on dosing or mixing protocols.
- Handling Must be handled only by qualified researchers with appropriate knowledge and facilities.
- Legal Notice This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.